Skip to main content

Table 3 Multivariate logistic regression analysis of predictive factors for treatment response in each lesion

From: Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Parameter Category P-value OR 95% CI
Age 0.372 0.846 0.586–1.222
Gender male   1  
female 0.274 0.116 0.002–5.503
Baseline diameter 0.999 1.000 0.960–1.042
Baseline SUVmax 0.866 1.069 0.494–2.311
Metastatic site lung   1  
non-lung 0.271 3.215 0.403–25.665
Elevation of SUVmax no   1  
yes 0.025 13.087 1.373–124.716
Decrease in diameter no   1  
yes 0.313 2.889 0.367–22.731
  1. CI Confidence interval, OR Odds ratio